Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Gufic Biosciences Limited (NSE: GUFICBIO), ISIN INE742B01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GUFICBIO last traded at ₹468.90 (+8.96%), with a 52-week range of ₹268.00 to ₹467.80 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 72.50%, FIIs 0.44%, DIIs 3.38%, mutual funds 3.03%.
EquiSense Score (ECS): 70/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.